Increasing plasma free fatty acids in healthy subjects induces aortic distensibility changes seen in obesity

Circ Cardiovasc Imaging. 2012 May 1;5(3):367-75. doi: 10.1161/CIRCIMAGING.111.971804. Epub 2012 Apr 5.

Abstract

Background: Elevated free fatty acid (FFA) levels are known to impair aortic elastic function. In obesity, FFA levels are elevated and aortic distensibility (AD) reduced in a pattern that predominantly affects the distal aorta. Despite this, the role of FFAs in obesity-related aortic stiffness remains unclear.

Methods and results: Using vascular MRI, we aimed to determine if (1) FFA level correlated with AD in obesity; and (2) whether elevating FFA acutely and subacutely in normal-weight subjects reproduced the distal pattern of AD change in obesity. To do this, regional AD was recorded in 35 normal-weight and 70 obese subjects and then correlated with FFA levels. When compared with normal weight, obesity was associated with reduced AD in a pattern predominantly affecting the distal aorta (ascending aorta by -22%, proximal descending aorta by -25%, and abdominal aorta by -35%; P<0.001). After controlling for age, blood pressure, and body mass index, FFA levels remained negatively correlated with abdominal AD (r=-0.43, P<0.01). In 2 further normal-weight groups, AD was recorded before and after elevation of FFA levels with intralipid infusion (by +535%, n=9) and a 5-day high-fat, low-carbohydrate diet (by +48%, n=14).

Conclusions: Both intralipid infusion and a low-carbohydrate diet resulted in reduced abdominal AD (infusion -22%, diet -28%; both P<0.05), reproducing the distal pattern AD reduction seen in obesity. These findings suggest that elevated FFA impair AD in obesity and provide a potential therapeutic target to improve aortic elastic function in obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aorta / physiopathology*
  • Body Mass Index
  • Cohort Studies
  • Compliance
  • Diet, Carbohydrate-Restricted / methods
  • Diet, High-Fat / methods
  • Fatty Acids, Nonesterified / administration & dosage
  • Fatty Acids, Nonesterified / blood*
  • Female
  • Humans
  • Male
  • Obesity / blood*
  • Obesity / physiopathology*
  • Vascular Stiffness

Substances

  • Fatty Acids, Nonesterified